Literature DB >> 10965786

B-cell lymphoma-associated hemophagocytic syndrome: clinicopathological characteristics.

M Miyahara1, M Sano, K Shibata, M Matsuzaki, K Ibaraki, Y Shimamoto, O Tokunaga.   

Abstract

Seven patients with peripheral B-cell lymphoma associated with hemophagocytic syndrome are reported. In all cases, the histologic subtype was diffuse large B-cell lymphoma. Hemophagocytic features were noted in the bone marrow with lymphomatous infiltration. Hemophagocytic syndrome occurred with presentation of the lymphoma and was characterized by high fever, cytopenias, and elevated levels of lactate dehydrogenase, ferritin, C-reactive protein, and cytokines [interferon gamma, macrophage colony-stimulating factor, soluble interleukin (sIL)-2R, and IL-6] without evidence of infection. The phenotypes of lymphomas were suspected CD19+, CD20+, S-Ig+, CD10-, and coexpression of CD5 in some cases. Flow cytometric analysis showed a low CD4/CD8 ratio in peripheral blood and bone marrow. We suggest that the pathogenesis of hemophagocytic syndrome is hypercytokinemia induced by a proliferation of reactive CD8+ T cells. Previous reports of B-cell lymphoma with hemophagocytic syndrome demonstrated similar clinical manifestations and poor prognoses. The invasion patterns of these diffuse large B-cell lymphomas with hemophagocytosis may be classified into three groups: microscopic lymph-node involvement type, gross lymph-node involvement type, and splenic lymphoma type. Although hemophagocytic syndromes have been reported to be associated with T-cell lymphomas, our results indicate an association with diffuse large B-cell lymphoma.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10965786     DOI: 10.1007/s002770000155

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  15 in total

1.  CD5+ diffuse large B-cell lymphoma with hemophagocytosis.

Authors:  Jan K Davidson-Moncada; Emily McDuffee; Mark Roschewski
Journal:  J Clin Oncol       Date:  2012-11-26       Impact factor: 44.544

Review 2.  Hemophagocytic Syndrome and Critical Illness: New Insights into Diagnosis and Management.

Authors:  Zuzana Tothova; Nancy Berliner
Journal:  J Intensive Care Med       Date:  2014-01-08       Impact factor: 3.510

3.  The serum cytokine profiles of lymphoma-associated hemophagocytic syndrome: a comparative analysis of B-cell and T-cell/natural killer cell lymphomas.

Authors:  Tatsuharu Ohno; Yasunori Ueda; Ken-ichi Nagai; Takayuki Takahashi; Yoshiteru Konaka; Teruyuki Takamatsu; Takayo Suzuki; Masataka Sasada; Takashi Uchiyama
Journal:  Int J Hematol       Date:  2003-04       Impact factor: 2.490

4.  Successful treatment with recombinant thrombomodulin for B-cell lymphoma-associated hemophagocytic syndrome complicated by disseminated intravascular coagulation.

Authors:  Masahiro Uni; Akihide Yoshimi; Hiroaki Maki; Daichi Maeda; Kumi Nakazaki; Fumihiko Nakamura; Masashi Fukayama; Mineo Kurokawa
Journal:  Int J Clin Exp Pathol       Date:  2013-05-15

5.  Nationwide survey of hemophagocytic lymphohistiocytosis in Japan.

Authors:  Eiichi Ishii; Shouichi Ohga; Shinsaku Imashuku; Masaki Yasukawa; Hiroyuki Tsuda; Ikuo Miura; Ken Yamamoto; Hisanori Horiuchi; Kenzo Takada; Koichi Ohshima; Shigeo Nakamura; Naoko Kinukawa; Kazuo Oshimi; Keisei Kawa
Journal:  Int J Hematol       Date:  2007-07       Impact factor: 2.490

6.  Secondary hemophagocytic lymphohistiocytosis: a case report.

Authors:  Lia Salvati; Anita Di Renzo; Sergio Moscardelli; Laura Natali; Ferri Claudio; Angelo Viscido
Journal:  Acta Biomed       Date:  2021-04-30

Review 7.  Enterovirus-associated hemophagocytic syndrome in children with malignancy: report of three cases and review of the literature.

Authors:  Katerina Katsibardi; Maria A Moschovi; Maria Theodoridou; Nicholas Spanakis; Panagiotis Kalabalikis; Athanassios Tsakris; Fotini Tzortzatou-Stathopoulou
Journal:  Eur J Pediatr       Date:  2007-02-22       Impact factor: 3.860

8.  Simultaneous manifestation of fulminant infectious mononucleosis with haemophagocytic syndrome and B-cell lymphoma in X-linked lymphoproliferative disease.

Authors:  Boris Hügle; Itziar Astigarraga; Jan-Inge Henter; Anna Porwit-MacDonald; Alfons Meindl; Volker Schuster
Journal:  Eur J Pediatr       Date:  2006-10-21       Impact factor: 3.860

9.  Treatment outcomes with CHOP chemotherapy in adult patients with hemophagocytic lymphohistiocytosis.

Authors:  Ho-Jin Shin; Joo Seop Chung; Je-Jung Lee; Sang Kyun Sohn; Young Jin Choi; Yeo-Kyeoung Kim; Deok-Hwan Yang; Hyeoung-Joon Kim; Jong Gwang Kim; Young Don Joo; Won Sik Lee; Chang-Hak Sohn; Eun Yup Lee; Goon Jae Cho
Journal:  J Korean Med Sci       Date:  2008-06       Impact factor: 2.153

10.  Adult-onset Still's disease with disseminated intravascular coagulation and multiple organ dysfunctions dramatically treated with cyclosporine A.

Authors:  Jae-Hong Park; Joong Ho Bae; Yeon-Soo Choi; Hye-Soon Lee; Jae-Bum Jun; Sungsoo Jung; Dae-Hyun Yoo; Sang-Cheol Bae; Tae-Hwan Kim
Journal:  J Korean Med Sci       Date:  2004-02       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.